Skip to main content
. Author manuscript; available in PMC: 2013 Sep 4.
Published in final edited form as: Mol Pharm. 2012 Aug 6;9(9):2677–2685. doi: 10.1021/mp300243w

Figure 5.

Figure 5

Morphology of H. pylori SS1 bacteria in their spiral form (A–C) and coccoid form (D–F) exposed to different treatments. In (A) and (D), bacteria were treated with PBS; in (B) and (E), bacteria were treated with LLA pre-dissolved in DMSO; in (C) and (F), bacteria were treated with LipoLLA. In all experiments, initial concentration of the bacteria was 5×106 CFU/mL and drug concentration was 200 µg/mL (referring to LLA). All samples were treated for 30 min before glutaralderhyde fixation. The scale bar in the image represents 1 µm.